CBPartners was founded in 2012 with a mission to provide pharmaceutical companies with recommendations on increasing patient access to crucial medicines around the world. They serve a variety of clients ranging from global pharmaceutical/biopharmaceutical companies to ministries of health in emerging markets. Their experiences span the entire lifecycle from discovery/development, through licensing and product launch, to government policy development. Their US operations are run out of New York City and San Francisco. London, UK is their European regional hub, and Asian engagements are anchored in Shanghai, China.